Short answer · Medically reviewed summary · Last updated: 2026-05-08
Hyper-IgD Syndrome (HIDS), or Hyperimmunoglobulinemia D with recurrent fever, is a rare autoinflammatory condition characterized by recurrent, lifelong episodes of high fever typically lasting three to seven days. These episodes are frequently accompanied by systemic symptoms such as abdominal pain, skin rashes, joint inflammation, and painful cervical lymphadenopathy. What are the primary symptoms of Hyper-IgD Syndrome? The hallmark of Hyper-IgD Syndrome is the predictable recurrence of inflammatory flares triggered by vaccination, minor trauma, or stress.
Hyper-IgD Syndrome (HIDS), or Hyperimmunoglobulinemia D with recurrent fever, is a rare autoinflammatory condition characterized by recurrent, lifelong episodes of high fever typically lasting three to seven days. These episodes are frequently accompanied by systemic symptoms such as abdominal pain, skin rashes, joint inflammation, and painful cervical lymphadenopathy.
The hallmark of Hyper-IgD Syndrome is the predictable recurrence of inflammatory flares triggered by vaccination, minor trauma, or stress. During a flare, patients experience a sudden onset of fever often exceeding 39°C (102.2°F). Clinical data indicates that the following symptoms are most frequently reported by those living with Hyper-IgD Syndrome:
For the six members of the Hyper-IgD Syndrome community on DiseaseMaps.org, the unpredictable nature of these flares is the most challenging aspect. Because symptoms can be debilitating, patients often face frequent school or work absences. Chronic fatigue and the physical toll of systemic inflammation can significantly impact long-term quality of life, though many individuals remain asymptomatic between flares.
While Hyper-IgD Syndrome is chronic, you should seek urgent medical evaluation if you experience signs of amyloidosis, a rare but serious complication where protein deposits damage organs, particularly the kidneys. Additionally, severe abdominal pain that mimics an acute surgical abdomen requires immediate professional assessment to rule out complications like bowel obstruction or peritonitis.
In most patients, the frequency of Hyper-IgD Syndrome flares tends to decrease as they reach adulthood. While the severity of individual episodes remains variable, the systemic inflammation associated with Hyper-IgD Syndrome is managed through targeted therapies, such as IL-1 inhibitors, which have transformed the management of the disease for many patients.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment.